Can Korea’s biosimilar project stay afloat?

Influenced by US midterm elections results 2010 that the Republicans registered thumping victories in congressional elections and they have intensified their opposition to President Barack Obama’s healthcare reform of 2010, a number of the world’s leading generic markers are moving toward the development of biopharmaceutical products instead of biosimilars.

Bio-similars, known as follow-on p...